United Capital Financial Advisers, LLC Guardant Health, Inc. Transaction History

United Capital Financial Advisers, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $984,680 - $1.34 Million	-11,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $111,906 - $149,748	1,133 Added 11.37%	11,100 $1.39 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $65,862 - $99,408	600 Added 6.41%	9,967 $1.24 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $222,955 - $314,320	1,755 Added 23.06%	9,367 $1.43 Million
Q4 2020 Feb 17, 2021	BUY	$99.96 - $135.93 $760,895 - $1.03 Million	7,612 New	7,612 $981,000
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $164,780 - $247,868	-2,791 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $28,376 - $39,486	-477 Reduced 14.6%	2,791 $218,000
Q3 2019 Feb 14, 2020	BUY	$62.59 - $110.3 $204,544 - $360,460	3,268 New	3,268 $209,000
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $213,306 - $375,902	-3,408 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $3,708 - $5,284	58 Added 1.73%	3,408 $294,000
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $114,904 - $328,233	3,350 New	3,350 $257,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.